WASHINGTON—The Food and Drug Administration plans new medical-device approval processes to speed products’ entry to the U.S. market, mirroring the desires of industry and President Donald Trump to ...
There is a new price surge in the pharmaceutical industry—not for medications, instead for a limited number of government-issued vouchers that drug makers, including AbbVie Inc.ABBV-2.86%decrease; red ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results